Liver Cirrhosis Network Cohort Study

NCT05740358 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1222

Last updated 2026-01-13

No results posted yet for this study

Summary

Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months (180 days), with opportunities to complete specific visit components via telehealth or remotely. Visits will include collection of questionnaire data and the in-person visits will include questionnaires, physical exams, imaging, and sample collection.

Conditions

  • Cirrhosis
  • Cirrhosis, Liver
  • Cirrhosis Early
  • Cirrhosis Due to Hepatitis B
  • Cirrhosis Advanced
  • Cirrhosis Infectious
  • Cirrhosis Alcoholic
  • Cirrhosis, Biliary
  • Cirrhosis Cryptogenic
  • Cirrhosis Due to Hepatitis C
  • Cirrhosis Due to Primary Sclerosing Cholangitis
  • Autoimmune Hepatitis

Sponsors & Collaborators

  • The Cleveland Clinic

    collaborator OTHER
  • Columbia University

    collaborator OTHER
  • Weill Medical College of Cornell University

    collaborator OTHER
  • Duke University

    collaborator OTHER
  • Mayo Clinic

    collaborator OTHER
  • University of Miami

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • University of California, San Diego

    collaborator OTHER
  • University of California, San Francisco

    collaborator OTHER
  • LAC+USC Medical Center

    collaborator OTHER
  • Virginia Commonwealth University

    collaborator OTHER
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH
  • National Cancer Institute (NCI)

    collaborator NIH
  • University of Southern California

    collaborator OTHER
  • Central Virginia Veterans Healthcare System

    collaborator UNKNOWN
  • Northwestern University

    lead OTHER

Principal Investigators

  • Abigail Smith · Northwestern University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-18
Primary Completion
2030-10-24
Completion
2030-10-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05740358 on ClinicalTrials.gov